Smith+Nephew gets FDA 510(k) clearance for LANDMARK Total Knee
Smith+Nephew says it received U.S. FDA 510(k) clearance for its LANDMARK Total Knee System and has completed the first surgical cases.
Smith+Nephew (LSE:SN, NYSE:SNN) said it has received 510(k) clearance from the U.S. Food and Drug Administration and has completed the first surgical cases with its LANDMARK Total Knee System, a next-generation knee replacement solution designed to r…